Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul K Nayak

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
AJOB Empirical Bioethics|September 27, 2017
Is it important to disclose how treatments are selected in clinical research and clinical care?Rahul K Nayak, David Wendler
Health Affairs (Project Hope)|October 8, 2014
The ethics of 'fail first': guidelines and practical scenarios for step therapy coverage policiesRahul K Nayak, Steven D Pearson
Frontiers in Oncology|August 26, 2022
Maintenance therapy for AML after allogeneic HCTRahul K Nayak, Yi-Bin Chen
BMJ (Clinical Research Ed.)|October 25, 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort studyRahul K Nayak, Jerry Avorn, Aaron S Kesselheim
Nature Reviews. Clinical Oncology|October 4, 2024
The high costs of anticancer therapies in the USA: challenges, opportunities and progressShelley A Jazowski, Rahul K Nayak, Stacie B Dusetzina
Clinical Lymphoma, Myeloma & Leukemia|September 4, 2023
SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK InhibitorsRahul K Nayak, Drew Gerber, Chen Zhang, et al.
Current Cardiology Reports|April 25, 2023
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?Micah Johnson, Sanjay Kishore, Rahul K Nayak, et al.
Annals of Internal Medicine|July 29, 2015
Pragmatic Randomized Trials Without Standard Informed Consent?: A National SurveyRahul K Nayak, David Wendler, Franklin G Miller, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapyRahul K Nayak, Meili Aiello, Laneisha Marielis Maldonado, et al.
Southern Medical Journal|November 3, 2020
Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic EncephalopathyPatricia P Bloom, Samuel J Miller, Rahul K Nayak, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AJOB Empirical Bioethics|September 27, 2017
Is it important to disclose how treatments are selected in clinical research and clinical care?Rahul K Nayak, David Wendler
Health Affairs (Project Hope)|October 8, 2014
The ethics of 'fail first': guidelines and practical scenarios for step therapy coverage policiesRahul K Nayak, Steven D Pearson
Frontiers in Oncology|August 26, 2022
Maintenance therapy for AML after allogeneic HCTRahul K Nayak, Yi-Bin Chen
BMJ (Clinical Research Ed.)|October 25, 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort studyRahul K Nayak, Jerry Avorn, Aaron S Kesselheim
Nature Reviews. Clinical Oncology|October 4, 2024
The high costs of anticancer therapies in the USA: challenges, opportunities and progressShelley A Jazowski, Rahul K Nayak, Stacie B Dusetzina
Clinical Lymphoma, Myeloma & Leukemia|September 4, 2023
SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK InhibitorsRahul K Nayak, Drew Gerber, Chen Zhang, et al.
Current Cardiology Reports|April 25, 2023
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?Micah Johnson, Sanjay Kishore, Rahul K Nayak, et al.
Annals of Internal Medicine|July 29, 2015
Pragmatic Randomized Trials Without Standard Informed Consent?: A National SurveyRahul K Nayak, David Wendler, Franklin G Miller, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapyRahul K Nayak, Meili Aiello, Laneisha Marielis Maldonado, et al.
Southern Medical Journal|November 3, 2020
Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic EncephalopathyPatricia P Bloom, Samuel J Miller, Rahul K Nayak, et al.
Pageof 2